Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 19 - Hybrid peptides
Patents for C07K 19 - Hybrid peptides (29,428)
08/1998
08/11/1998US5792838 Method for stabilizing immunoglobulin compositions
08/11/1998US5792645 Protein-polycation nucleic acid complexes and methods of use
08/11/1998US5792456 Mutant BR96 antibodies reactive with human carcinomas
08/06/1998WO1998033513A1 Soluble ctla4 mutant molecules and uses thereof
08/06/1998WO1998024906A3 Isolated mammalian monocyte cell genes; related reagents
08/06/1998CA2278771A1 Soluble ctla4 mutant molecules and uses thereof
08/05/1998EP0856054A1 Monoclonal antibody br110 and uses thereof
08/05/1998CN1189840A Hybrid molecules between heat-labile enterotoxin and cholera toxin B subunits
08/04/1998US5790421 Computer apparatus for expressing a three dimensional structure of a G-CSF molecule or analogs thereof
08/04/1998US5789377 Blocking tumor necrosis factor
08/04/1998US5788970 Chimeric infectious bursal disease virus CDNA clones, expression products and vaccines based thereon
08/04/1998CA2098296C Pseudomonas peptide composition and method for producing the same
07/1998
07/30/1998WO1998032866A1 Fusion proteins for intracellular and intercellular transport and their uses
07/30/1998WO1998025958A3 Mammalian cell surface antigens comprising structural motifs characteristic of a member of the TNF ligand family
07/30/1998CA2278002A1 Fusion proteins for intracellular and intercellular transport and their uses
07/29/1998EP0854931A1 Coiled-coil heterodimer methods and compositions for the detection and purification of expressed proteins
07/29/1998EP0854928A2 Multi-functional hematopoietic receptor agonists
07/29/1998EP0854922A1 Improvements in or relating to protection against intracellular infection
07/28/1998US5786163 BNP antibody and immunoassay using it
07/28/1998US5785970 Method of the treatment of gastrointestinal disorders with immunogenic compositions against gastrin
07/23/1998WO1998031819A1 Expression in yeast of antigenically active, recombinant hybrid glutamic acid decarboxylase
07/23/1998WO1998021337A3 C3 BINDING PROTEIN OF $i(STREPTOCOCCUS PNEUMONIAE)
07/23/1998CA2278787A1 Expression in yeast of antigenically active, recombinant hybrid glutamic acid decarboxylase
07/22/1998EP0854185A2 Assay receptor proteins and ligands
07/22/1998EP0853681A1 ARF-p19, A NOVEL REGULATOR OF THE MAMMALIAN CELL CYCLE
07/16/1998WO1998030706A1 Compounds, compositions and methods for the endocytic presentation of immunosuppressive factors
07/16/1998WO1998020343A3 Receptor binding assay, appropriate recombinant fusion receptor for said assay, vector for its production and reagent kit for implementing the receptor binding assay
07/16/1998CA2277582A1 Compounds, compositions and methods for the endocytic presentation of immunosuppressive factors
07/15/1998EP0852502A1 Lantibiotic mutants and chimeras of enhanced stability and activity
07/15/1998EP0528926B1 Soluble peptide analogues containing binding sites
07/15/1998EP0497883B1 Compositions and their use for promoting immunopotentiation
07/14/1998US5780601 Method for purification of protein "e" from haemophilus influenzae
07/14/1998US5780592 Transplant, antitumor
07/14/1998US5780030 Passive vaccine against Lyme disease
07/09/1998WO1998029540A2 RECOMBINANT FUSION PROTEINS BASED ON RIBOSOME-INACTIVATING PROTEINS OF EUROPEAN MISTLETOE $i(VISCUM ALBUM)
07/08/1998EP0852234A1 Antigenic peptide compounds and immunoassay method
07/08/1998EP0851931A1 Subtilisin inhibitor of streptomyces venezuelae, and use of the gene sequences for expression and/or secretion of heterologous proteins in streptomyces
07/08/1998EP0851874A1 Novel variants of green fluorescent protein, gfp
07/08/1998EP0851764A1 Heat shock protein-based vaccines and immunotherapies
07/08/1998EP0571538B1 Structural gene of pneumococcal protein
07/08/1998EP0528931B1 Humanized chimeric anti-icam-1 antibodies, methods of preparation and use
07/08/1998CN1187217A Botulinum toxin derivatives able to modify peripheral sensory afferent functions
07/07/1998US5776895 Compositions of G-CSF and TNF-BP for prophylaxis and treatment of septic shock
07/07/1998US5776675 Measuring change in cell phenotype
07/02/1998WO1998028621A1 Vegf-b/receptor complex and uses thereof
07/02/1998WO1998028427A1 Ob fusion protein compositions and methods
07/02/1998WO1998028425A1 Mammalian cytokine related to il10
07/02/1998CA2275183A1 Ob fusion protein compositions and methods
07/02/1998CA2275138A1 Mammalian cytokine related to il10
07/02/1998CA2274675A1 Vegf-b/receptor complex and uses thereof
07/01/1998EP0850308A2 Hcv ns3 protein fragments having helicase activity and improved solubility
07/01/1998EP0850305A2 Compounds and methods for diagnosis of tuberculosis
07/01/1998EP0850250A1 Ubiquitin conjugating enzymes having transcriptional repressor activity
07/01/1998EP0804215A4 Template assembled synthetic protein
07/01/1998EP0662093A4 Hiv immunotherapeutics.
07/01/1998EP0546124B1 Multidomain hematopoiesis stimulators
07/01/1998CN1186514A Process for controlling sialylation of protein produced by mammalian cell culture
07/01/1998CN1186500A Monoclonal antibodies against HIV-1 and vaccines made thereof
06/1998
06/30/1998US5773280 Monoclonal antibody to a human MDR1 multidrug resistance gene product, and uses
06/30/1998US5773253 MYPPPY variants of CTL A4 and uses thereof
06/30/1998US5773243 Cobra venom factors
06/30/1998US5773228 Activation-dependent protein expressed on the surface of activated platelets and antibodies thereto
06/30/1998US5772997 Monoclonal antibodies directed to the HER2 receptor
06/30/1998CA1339936C Animal interferons
06/25/1998WO1998027115A1 Oil bodies and associated proteins as affinity matrices
06/24/1998EP0849278A1 Low crosslinked conjugates of photoproteins
06/24/1998EP0848755A1 Vegf-related protein
06/24/1998EP0848718A1 Cytolytic bradykinin antagonists
06/23/1998US5770719 Isolated nucleic acid containing promoter sequence from a gene which codes for an adenosine triphosphatase
06/23/1998US5770704 Receptor activation with inactive hepatocyte growth factor ligands
06/23/1998US5770442 Comprises a nonnative amino acid sequence which is a protease recognition sequence
06/23/1998US5770421 Human ALK protein tyrosine kinase
06/23/1998US5770203 Modified cholera toxin based on mutagenized subunit A
06/23/1998US5770197 Methods for regulating the immune response using B7 binding molecules and IL4-binding molecules
06/23/1998US5770196 Modified antibody variable domains and therapeutic uses thereof
06/23/1998US5770195 Antitumor
06/23/1998CA2222823A1 Composition of slap-130, a slp-76 associated protein and methods of use therefor
06/18/1998WO1998026080A1 Method for expression of heterologous proteins in yeast
06/18/1998WO1998025963A1 Analysis and separation of platelet-derived growth factor proteins
06/18/1998WO1998025959A2 Secreted human proteins
06/18/1998WO1998025958A2 Mammalian cell surface antigens comprising structural motifs characteristic of a member of the tnf ligand family
06/18/1998CA2707726A1 Novel expression vectors containing accessory molecule ligand genes and their use for immunomodulation and treatment of malignancies and autoimmune disease
06/18/1998CA2274801A1 Mammalian cell surface antigens; related reagents
06/17/1998EP0848061A2 Self-enhancing, pharmacologically controllable expression systems
06/16/1998US5767250 Complexes comprising truncated CMV gH polypeptides and escort proteins
06/16/1998US5767243 A complex of human afamin and apolipoprotein a1; a monoclonal antibody specific for human afamin
06/16/1998US5767242 Isolated dimeric fibroblast activation protein alpha, and uses thereof
06/16/1998US5767241 Soluble form of GMP-140
06/16/1998US5767067 Follicle stimulating hormone and pharmaceutical compositions containing same
06/16/1998US5766921 Hybrid protein C
06/16/1998US5766886 Modified antibody variable domains
06/16/1998US5766850 Human β2 integrin α subunit
06/11/1998WO1998024906A2 Isolated mammalian monocyte cell genes; related reagents
06/11/1998WO1998024902A1 Adaptor protein frs2 and related products and methods
06/11/1998WO1998024475A1 Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof
06/11/1998WO1998012910A3 Novel CREBa isoform
06/11/1998WO1998006749A3 Soluble monovalent and multivalent mhc class ii fusion proteins, and uses therefor
06/11/1998CA2274145A1 Adaptor protein frs2 and related products and methods
06/11/1998CA2273199A1 Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof
06/11/1998CA2224334A1 Self-enhancing, pharmacologically controllable expression systems
1 ... 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 ... 295